Smith & Nephew SNATS - 21 Year Stock Price History | SNN

Historical daily share price chart and data for Smith & Nephew SNATS since 1999 adjusted for splits. The latest closing stock price for Smith & Nephew SNATS as of March 27, 2020 is 35.20.
  • The all-time high Smith & Nephew SNATS stock closing price was 51.64 on February 20, 2020.
  • The Smith & Nephew SNATS 52-week high stock price is 52.26, which is 48.5% above the current share price.
  • The Smith & Nephew SNATS 52-week low stock price is 26.07, which is 25.9% below the current share price.
  • The average Smith & Nephew SNATS stock price for the last 52 weeks is 44.27.
Smith & Nephew SNATS Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 44.5640 48.2700 51.6400 27.7800 35.2000 -26.77%
2019 42.7863 36.4000 48.5900 35.5100 48.0700 28.60%
2018 36.3446 34.9000 39.4400 32.4000 37.3800 6.77%
2017 34.1090 29.9900 38.5000 29.9000 35.0100 16.39%
2016 32.3880 34.8000 35.0600 27.1100 30.0800 -15.51%
2015 35.0108 35.9500 37.7800 32.4800 35.6000 -3.10%
2014 32.9098 28.3360 38.9080 28.3360 36.7400 28.03%
2013 24.0164 22.2920 28.7400 21.1600 28.6960 29.49%
2012 20.3023 19.5560 22.4640 18.0520 22.1600 15.06%
2011 20.5597 21.0400 24.0760 16.8680 19.2600 -8.37%
2010 19.1278 20.6520 21.5760 16.5160 21.0200 2.54%
2009 15.8762 13.0400 20.5520 12.2280 20.5000 58.67%
2008 21.6752 23.0520 27.4280 12.1560 12.9200 -43.75%
2007 24.1161 20.9480 27.1080 20.8280 22.9680 9.73%
2006 17.8203 18.9440 21.0600 14.7800 20.9320 12.90%
2005 19.1965 20.3320 21.1320 16.1040 18.5400 -10.45%
2004 19.6518 16.7360 23.2000 16.3200 20.7040 23.47%
2003 13.2164 12.3720 16.9200 10.7200 16.7680 36.55%
2002 11.5938 12.0600 12.7820 9.6800 12.2800 0.99%
2001 9.9700 9.2000 12.1800 8.3700 12.1600 31.83%
2000 7.9306 8.2180 9.2240 6.1403 9.2240 12.01%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $15.108B $5.138B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $133.686B 23.40
Medtronic (MDT) Ireland $123.215B 16.57
Stryker (SYK) United States $61.179B 19.77
Boston Scientific (BSX) United States $43.868B 19.76
Baxter (BAX) United States $40.667B 24.82
Lonza Group Ag (LZAGY) Switzerland $30.356B 0.00
Coloplast (CLPBY) Denmark $29.419B 45.40
EssilorLuxottica Societe Anonyme (ESLOY) France $26.277B 0.00
Terumo (TRUMY) Japan $23.940B 29.88
ResMed (RMD) United States $21.189B 36.81
Zimmer Biomet Holdings (ZBH) United States $20.816B 12.81
Sunny Optical Technology (SNPTF) China $15.257B 0.00
Insulet (PODD) United States $11.175B 683.73
Bio-Rad Laboratories (BIO) United States $10.212B 47.73
William Demant Holdings (WILYY) Denmark $7.898B 0.00
Hill-Rom Holdings (HRC) United States $6.846B 19.69
DiaSorin S.p.A (DSRLF) Italy $6.714B 0.00
Perrigo (PRGO) Ireland $6.335B 11.55
GN STORE NORD (GNNDY) Denmark $5.510B 28.47
Canopy Growth (CGC) Canada $5.296B 0.00
Haemonetics (HAE) United States $5.273B 32.46
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
ICU Medical (ICUI) United States $3.803B 24.84
Quidel (QDEL) United States $3.726B 32.71
Neogen (NEOG) United States $3.131B 53.04
GW Pharmaceuticals (GWPH) United Kingdom $2.677B 0.00
NuVasive (NUVA) United States $2.614B 20.21
Agios Pharmaceuticals (AGIO) United States $2.586B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.532B 0.00
Envista Holdings (NVST) United States $2.464B 0.00
National Vision Holdings (EYE) United States $1.777B 29.93
Cardiovascular Systems (CSII) United States $1.219B 0.00
AtriCure (ATRC) United States $1.217B 0.00
TG Therapeutics (TGTX) United States $1.175B 0.00
Aurora Cannabis (ACB) Canada $1.058B 0.00
NanoString Technologies (NSTG) United States $0.993B 0.00
Aphria (APHA) $0.887B 0.00
VAREX IMAGING (VREX) United States $0.814B 16.91
Phibro Animal Health (PAHC) United States $0.810B 16.02
InMode (INMD) Israel $0.779B 0.00
Cerus (CERS) United States $0.707B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.628B 113.00
Omeros (OMER) United States $0.611B 0.00
PetIQ (PETQ) United States $0.605B 16.47
Eagle Pharmaceuticals (EGRX) United States $0.581B 34.52
OraSure Technologies (OSUR) United States $0.502B 62.23
Lantheus Holdings (LNTH) United States $0.501B 11.26
LeMaitre Vascular (LMAT) United States $0.489B 27.52
Surmodics (SRDX) United States $0.465B 53.42
Quanterix (QTRX) United States $0.459B 0.00
Zynex (ZYXI) United States $0.364B 39.64
Owens & Minor (OMI) United States $0.350B 9.57
Vapotherm (VAPO) United States $0.343B 0.00
Organigram Holdings (OGI) Canada $0.338B 0.00
Repro-Med Systems (KRMD) United States $0.318B 200.50
Utah Medical Products (UTMD) United States $0.305B 21.83
Meridian Bioscience (VIVO) United States $0.299B 12.02
MacroGenics (MGNX) United States $0.296B 0.00
HEXO (HEXO) $0.295B 0.00
Exagen (XGN) United States $0.219B 0.00
Cytosorbents (CTSO) United States $0.214B 0.00
Female Health (VERU) United States $0.209B 0.00
BioLife Solutions (BLFS) United States $0.206B 126.00
Rockwell Medical (RMTI) United States $0.169B 0.00
Viemed Healthcare (VMD) United States $0.163B 18.39
InfuSystems Holdings (INFU) United States $0.161B 135.33
Evolus (EOLS) United States $0.152B 0.00
United Health Products (UEEC) United States $0.146B 0.00
Bovie Medical (APYX) United States $0.135B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.118B 0.00
Liberty Health Sciences (LHSIF) Canada $0.113B 0.00
Chimerix (CMRX) United States $0.093B 0.00
Chembio Diagnostics (CEMI) United States $0.092B 0.00
Fonar (FONR) United States $0.091B 6.64
Green Organic Dutchman Holdings (TGODF) Canada $0.078B 0.00
MTech Acquisition (KERN) United States $0.077B 0.00
Brainsway (BWAY) Israel $0.073B 0.00
United-Guardian (UG) United States $0.062B 13.08
Nephros (NEPH) United States $0.057B 0.00
Wound Management Technologies (SMTI) United States $0.054B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.051B 0.00
GUARDION HEALTH (GHSI) United States $0.033B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
FSD PHARMA INC (HUGE) Canada $0.028B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
Senestech (SNES) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00
Akers Biosciences Inc (AKER) United States $0.001B 0.00